Ngā hua rapu kaituhi

1

Tissue-Specific Delivery of CRISPR Therapeutics: Strategies and Mechanisms of Non-Viral Vectors mā Shalaby, Karim, Aouida, Mustapha, El-Agnaf, Omar

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
2

Diagnostic, Prognostic, and Mechanistic Biomarkers of Diabetes Mellitus-Associated Cognitive Decline mā Ehtewish, Hanan, Arredouani, Abdelilah, El-Agnaf, Omar

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
3

Gene-Based Therapeutics for Parkinson’s Disease mā Shalaby, Karim E., El-Agnaf, Omar M. A.

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
4

Paving the Way toward Personalized Medicine: Current Advances and Challenges in Multi-OMICS Approach in Autism Spectrum Disorder for Biomarkers Discovery and Patient Stratification mā Mesleh, Areej G., Abdulla, Sara A., El-Agnaf, Omar

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
5

Protein Aggregation in the Brain: The Molecular Basis for Alzheimer’s and Parkinson’s Diseases mā Irvine, G Brent, El-Agnaf, Omar M, Shankar, Ganesh M, Walsh, Dominic M

I whakaputaina 2008

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
6

Rapid Assessment of CRISPR Transfection Efficiency and Enrichment of CRISPR Induced Mutations Using a Dual-Fluorescent Stable Reporter System mā Shalaby, Karim E., Aouida, Mustapha, Gupta, Vijay, Ghanem, Simona S., El-Agnaf, Omar M. A.

I whakaputaina 2022

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
7

A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein mā Landeck, Natalie, Hall, Hélène, Ardah, Mustafa T., Majbour, Nour K., El-Agnaf, Omar M. A., Halliday, Glenda, Kirik, Deniz

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
8

Decrease in Plasma Levels of α-Synuclein Is Evident in Patients with Parkinson’s Disease after Elimination of Heterophilic Antibody Interference mā Ishii, Ryotaro, Tokuda, Takahiko, Tatebe, Harutsugu, Ohmichi, Takuma, Kasai, Takashi, Nakagawa, Masanori, Mizuno, Toshiki, El-Agnaf, Omar M. A.

I whakaputaina 2015

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
9

A First Tetraplex Assay for the Simultaneous Quantification of Total α-Synuclein, Tau, β-Amyloid(42) and DJ-1 in Human Cerebrospinal Fluid mā Kruse, Niels, Schlossmacher, Michael G., Schulz-Schaeffer, Walter J., Vanmechelen, Eugeen, Vanderstichele, Hugo, El-Agnaf, Omar M., Mollenhauer, Brit

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
10

RT-QuIC Using C-Terminally Truncated α-Synuclein Forms Detects Differences in Seeding Propensity of Different Brain Regions from Synucleinopathies mā Poggiolini, Ilaria, Erskine, Daniel, Vaikath, Nishant N., Ponraj, Janarthanan, Mansour, Said, Morris, Christopher M., El-Agnaf, Omar M. A.

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
11

Natural Alkaloid Compounds as Inhibitors for Alpha-Synuclein Seeded Fibril Formation and Toxicity mā Ghanem, Simona S., Fayed, Hend S., Zhu, Qi, Lu, Jia-Hong, Vaikath, Nishant N., Ponraj, Janarthanan, Mansour, Said, El-Agnaf, Omar M. A.

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
12

Expression, purification and characterization of α-synuclein fibrillar specific scFv from inclusion bodies mā Gupta, Vijay, Sudhakaran, Indulekha P., Islam, Zeyaul, Vaikath, Nishant N., Hmila, Issam, Lukacsovich, Tamas, Kolatkar, Prasanna R., El-Agnaf, Omar M. A.

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
13

Cerebrospinal Fluid α-Synuclein Species in Cognitive and Movements Disorders mā Constantinides, Vasilios C., Majbour, Nour K., Paraskevas, George P., Abdi, Ilham, Safieh-Garabedian, Bared, Stefanis, Leonidas, El-Agnaf, Omar M., Kapaki, Elisabeth

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
14

α-Synuclein Aggregation and Ser-129 Phosphorylation-dependent Cell Death in Oligodendroglial Cells mā Kragh, Christine L., Lund, Louise B., Febbraro, Fabia, Hansen, Hanne D., Gai, Wei-Ping, El-Agnaf, Omar, Richter-Landsberg, Christiane, Jensen, Poul Henning

I whakaputaina 2009

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
15

Phosphorylated exogenous alpha-synuclein fibrils exacerbate pathology and induce neuronal dysfunction in mice mā Karampetsou, Mantia, Ardah, Mustafa T., Semitekolou, Maria, Polissidis, Alexia, Samiotaki, Martina, Kalomoiri, Maria, Majbour, Nour, Xanthou, Georgina, El-Agnaf, Omar M. A., Vekrellis, Kostas

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
16

Systemic peptide mediated delivery of an siRNA targeting α-syn in the CNS ameliorates the neurodegenerative process in a transgenic model of Lewy body disease mā Spencer, Brian, Trinh, Ivy, Rockenstein, Edward, Mante, Michael, Florio, Jazmin, Adame, Anthony, El-Agnaf, Omar MA, Kim, Changyoun, Masliah, Eliezer, Rissman, Robert A.

I whakaputaina 2019

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
17

Complex I reductions in the nucleus basalis of Meynert in Lewy body dementia: the role of Lewy bodies mā Hatton, Christopher, Reeve, Amy, Lax, Nichola Zoe, Blain, Alasdair, Ng, Yi Shiau, El-Agnaf, Omar, Attems, Johannes, Taylor, John-Paul, Turnbull, Doug, Erskine, Daniel

I whakaputaina 2020

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
18

Anti-aging treatments slow propagation of synucleinopathy by restoring lysosomal function mā Kim, Dong-Kyu, Lim, Hee-Sun, Kawasaki, Ichiro, Shim, Yhong-Hee, Vaikath, Nishant N., El-Agnaf, Omar M. A., Lee, He-Jin, Lee, Seung-Jae

I whakaputaina 2016

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
19

Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer’s disease mā Majbour, Nour K., Chiasserini, Davide, Vaikath, Nishant N., Eusebi, Paolo, Tokuda, Takahiko, van de Berg, Wilma, Parnetti, Lucilla, Calabresi, Paolo, El-Agnaf , Omar M. A.

I whakaputaina 2017

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:
20

Preanalytical Stability of CSF Total and Oligomeric Alpha-Synuclein mā Abdi, Ilham Y., Majbour, Nour K., Willemse, Eline A. J., van de Berg, Wilma D. J., Mollenhauer, Brit, Teunissen, Charlotte E., El-Agnaf, Omar M.

I whakaputaina 2021

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa
Text

Tiaki ki tētahi rārangi

I tiakina i:

Ngā hua rapu - El‐Agnaf, Omar

Tissue-Specific Delivery of CRISPR Therapeutics: Strategies and Mechanisms of Non-Viral Vectors mā Shalaby, Karim, Aouida, Mustapha, El-Agnaf, Omar

Diagnostic, Prognostic, and Mechanistic Biomarkers of Diabetes Mellitus-Associated Cognitive Decline mā Ehtewish, Hanan, Arredouani, Abdelilah, El-Agnaf, Omar

Gene-Based Therapeutics for Parkinson’s Disease mā Shalaby, Karim E., El-Agnaf, Omar M. A.

Paving the Way toward Personalized Medicine: Current Advances and Challenges in Multi-OMICS Approach in Autism Spectrum Disorder for Biomarkers Discovery and Patient Stratification mā Mesleh, Areej G., Abdulla, Sara A., El-Agnaf, Omar

Protein Aggregation in the Brain: The Molecular Basis for Alzheimer’s and Parkinson’s Diseases mā Irvine, G Brent, El-Agnaf, Omar M, Shankar, Ganesh M, Walsh, Dominic M

Rapid Assessment of CRISPR Transfection Efficiency and Enrichment of CRISPR Induced Mutations Using a Dual-Fluorescent Stable Reporter System mā Shalaby, Karim E., Aouida, Mustapha, Gupta, Vijay, Ghanem, Simona S., El-Agnaf, Omar M. A.

A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein mā Landeck, Natalie, Hall, Hélène, Ardah, Mustafa T., Majbour, Nour K., El-Agnaf, Omar M. A., Halliday, Glenda, Kirik, Deniz

Decrease in Plasma Levels of α-Synuclein Is Evident in Patients with Parkinson’s Disease after Elimination of Heterophilic Antibody Interference mā Ishii, Ryotaro, Tokuda, Takahiko, Tatebe, Harutsugu, Ohmichi, Takuma, Kasai, Takashi, Nakagawa, Masanori, Mizuno, Toshiki, El-Agnaf, Omar M. A.

A First Tetraplex Assay for the Simultaneous Quantification of Total α-Synuclein, Tau, β-Amyloid(42) and DJ-1 in Human Cerebrospinal Fluid mā Kruse, Niels, Schlossmacher, Michael G., Schulz-Schaeffer, Walter J., Vanmechelen, Eugeen, Vanderstichele, Hugo, El-Agnaf, Omar M., Mollenhauer, Brit

RT-QuIC Using C-Terminally Truncated α-Synuclein Forms Detects Differences in Seeding Propensity of Different Brain Regions from Synucleinopathies mā Poggiolini, Ilaria, Erskine, Daniel, Vaikath, Nishant N., Ponraj, Janarthanan, Mansour, Said, Morris, Christopher M., El-Agnaf, Omar M. A.

Natural Alkaloid Compounds as Inhibitors for Alpha-Synuclein Seeded Fibril Formation and Toxicity mā Ghanem, Simona S., Fayed, Hend S., Zhu, Qi, Lu, Jia-Hong, Vaikath, Nishant N., Ponraj, Janarthanan, Mansour, Said, El-Agnaf, Omar M. A.

Expression, purification and characterization of α-synuclein fibrillar specific scFv from inclusion bodies mā Gupta, Vijay, Sudhakaran, Indulekha P., Islam, Zeyaul, Vaikath, Nishant N., Hmila, Issam, Lukacsovich, Tamas, Kolatkar, Prasanna R., El-Agnaf, Omar M. A.

Cerebrospinal Fluid α-Synuclein Species in Cognitive and Movements Disorders mā Constantinides, Vasilios C., Majbour, Nour K., Paraskevas, George P., Abdi, Ilham, Safieh-Garabedian, Bared, Stefanis, Leonidas, El-Agnaf, Omar M., Kapaki, Elisabeth

α-Synuclein Aggregation and Ser-129 Phosphorylation-dependent Cell Death in Oligodendroglial Cells mā Kragh, Christine L., Lund, Louise B., Febbraro, Fabia, Hansen, Hanne D., Gai, Wei-Ping, El-Agnaf, Omar, Richter-Landsberg, Christiane, Jensen, Poul Henning

Complex I reductions in the nucleus basalis of Meynert in Lewy body dementia: the role of Lewy bodies mā Hatton, Christopher, Reeve, Amy, Lax, Nichola Zoe, Blain, Alasdair, Ng, Yi Shiau, El-Agnaf, Omar, Attems, Johannes, Taylor, John-Paul, Turnbull, Doug, Erskine, Daniel

Anti-aging treatments slow propagation of synucleinopathy by restoring lysosomal function mā Kim, Dong-Kyu, Lim, Hee-Sun, Kawasaki, Ichiro, Shim, Yhong-Hee, Vaikath, Nishant N., El-Agnaf, Omar M. A., Lee, He-Jin, Lee, Seung-Jae

Preanalytical Stability of CSF Total and Oligomeric Alpha-Synuclein mā Abdi, Ilham Y., Majbour, Nour K., Willemse, Eline A. J., van de Berg, Wilma D. J., Mollenhauer, Brit, Teunissen, Charlotte E., El-Agnaf, Omar M.

Ngā utauta rapu: